S.V. Feinman

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

Stefan Zeuzem, S.V. Feinman, J. Rasenack et al. · New England Journal of Medicine · 2000 · 1.2K citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b

Erik H.C.J. Buster, Hajo J. Flink, Yılmaz Çakaloğlu et al. · Gastroenterology · 2008 · 396 citations · Full text

Pharmacy, Infectious Diseases, Hepatitis Pharmacotherapy +2

The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients #

Robert Flisiak, S.V. Feinman, Maciej Jabłkowski et al. · Hepatology · 2009 · 222 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Re-treatment of chronic hepatitis C with consensus interferon

Jenny Heathcote, Emmet B. Keeffe, Samuel S. Lee et al. · Hepatology · 1998 · 169 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests

M.A. Blajchman, Shelley B. Bull, S.V. Feinman · The Lancet · 1995 · 93 citations

Medicine, Hematology, Internal Medicine +11